This inventor holds 1 USPTO granted patent. Top assignee: Amersham International Plc. Active years: 1989.
Company Filing History:
Years Active: 1989
Title: The Innovations of Andrew B McEwen
Introduction
Andrew B McEwen is a notable inventor based in Streatham, GB. He has made significant contributions to the field of medical imaging, particularly through his innovative work on contrast agents for NMR scanning. His research has implications for understanding bone metabolism, which is crucial for various medical applications.
Latest Patents
Andrew B McEwen holds a patent for a contrast agent designed for NMR scanning. This patent involves complexes formed between an amino di- or poly-phosphonate and a paramagnetic metal ion, such as Gd³⁺. These complexes exhibit properties that allow them to target calcified tissue, making them useful for investigating bone metabolism through NMR scanning. Two preferred poly-phosphonates mentioned in his patent are ethylenediamine tetramethylphosphonate and meta-xylene-diamine tetramethylphosphonate.
Career Highlights
Throughout his career, Andrew has worked with Amersham International Plc, where he has been able to apply his expertise in the development of innovative medical imaging technologies. His work has contributed to advancements in the field, enhancing the capabilities of NMR scanning.
Collaborations
Andrew has collaborated with esteemed colleagues such as Peter J Sadler and Charles T Harding. These collaborations have likely enriched his research and contributed to the successful development of his patented technologies.
Conclusion
Andrew B McEwen's contributions to the field of medical imaging through his innovative patent demonstrate his commitment to advancing healthcare technology. His work continues to have a lasting impact on the understanding of bone metabolism and the capabilities of NMR scanning.